1. Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis

   • Mengxia Gao
   • Lingqun Zhu
   • Fei Chen

   Systematic Review 03 December 2022 Pages: 1 - 11

   

2. Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment

   • Xinyu Liu
   • Jian Shi
   • Fei Chen

   Review Article 03 December 2022 Pages: 13 - 22

   

3. Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

   • Amy Legg
   • Niamh Meagher
   • Steven Y. C. Tong

   Original Research Article Open access 10 October 2022 Pages: 23 - 33

   

4. Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

   • Amy Legg
   • Niamh Meagher
   • Steven Y. C. Tong

   Correction Open access 19 November 2022 Pages: 35 - 35

5. Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women

   • Feng Shao
   • Yi Jiang
   • Daniël Martijn Jonker

   Original Research Article Open access 07 December 2022 Pages: 37 - 44

   

6. Long-Term Safety and Effectiveness of Erenumab in Patients with Migraine: A Systematic Review and Single-Arm Meta-analysis

   • Fernanda Ferreira Bomtempo
   • Rebeka Bustamante Rocha
   • João Paulo Mota Telles

   Original Research Article 08 December 2022 Pages: 45 - 59

   

7. CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study)

   • Tanvi Patil
   • Emily Halsey
   • Davida Eppes

   Original Research Article 14 December 2022 Pages: 61 - 74

   

8. Gastric Glitch: A New Functional Disease Treated with Buspirone and Prucalopride in an N-of-1 Double-Blind Clinical Trial

   • Gabriela Ambrós
   • Ricardo Valões
   • Fernando Fornari

   Research Letter 12 November 2022 Pages: 75 - 78

   

9. Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”

   • Alina Wilkowska
   • Wiesław Jerzy Cubała

   Letter to the Editor 16 November 2022 Pages: 79 - 80

10. Correction to: Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”

    • Alina Wilkowska
    • Wiesław Jerzy Cubała

    Correction 02 December 2022 Pages: 81 - 81

11. Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”

    • Julia Diniz Grossi
    • Juliana Surjan
    • Acioly Luiz Tavares Lacerda

    Letter to the Editor 25 November 2022 Pages: 83 - 84